Clinical Trial Update: A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea [Phase 2]

View source ↗

Summary

A Phase 2 double-blind, randomized trial comparing incobotulinumtoxinA to saline injections for rosacea in the cheek region; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• IncobotulinumtoxinA (incobotulinumtoxinA)

Snippet

Sponsor: DeNova Research | Conditions: Rosacea | Phase 2 | Status: COMPLETED | Results posted: 2020-09-14